» Authors » Abbal Koirala

Abbal Koirala

Explore the profile of Abbal Koirala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 37
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Timlin H, Koirala A, Gross M, Geetha D, Kamel I, Atta M, et al.
Lupus . 2025 Feb; :9612033251321655. PMID: 39980455
Background: A kidney biopsy is essential for definitive histopathological diagnosis in lupus nephritis, informing therapeutic strategies. Current guidelines (ACR and EULAR/ERA-EDTA) do not include a kidney biopsy for patients with...
2.
Chang B, Koirala A, Geetha D
Front Nephrol . 2024 Dec; 4:1480968. PMID: 39726793
No abstract available.
3.
Koirala A, Sharma P, Jhaveri K, Jain K, Geetha D
Adv Kidney Dis Health . 2024 Nov; 31(6):485-495. PMID: 39577882
Rapidly progressive glomerulonephritis (RPGN) is a syndrome characterized by a swift decline in kidney function, often over a few months, accompanied by features of nephritic syndrome. It can result in...
4.
Juanet C, Hassi I, Koirala A
Glomerular Dis . 2024 Nov; 4(1):189-199. PMID: 39507613
Background: Pauci-immune glomerulonephritis (PIGN) is typically secondary to antineutrophil cytoplasmic antibodies (ANCA) small-vessel vasculitis. However, some cases lack detectable circulating ANCA and are called ANCA-negative PIGN (seronegative PIGN). The reported...
5.
Koirala A, Akilesh S, Jefferson J
Adv Kidney Dis Health . 2024 Jul; 31(4):290-298. PMID: 39084754
Collapsing glomerulopathy (CG) is a pattern of kidney injury characterized by segmental or global collapse of the glomerular tuft associated with overlying epithelial cell hyperplasia. Although CG may be idiopathic,...
6.
Aslam A, Koirala A
Glomerular Dis . 2023 Oct; 3(1):211-219. PMID: 37901702
Background: Minimal change disease and primary FSGS are podocytopathies but are also immune-mediated diseases. Rituximab acts via multiple mechanisms by tilting the balance between autoreactive B and T cells in...
7.
Alachkar N, Delsante M, Greenberg R, Koirala A, Alhamad T, Abdalla B, et al.
Transplantation . 2023 May; 107(9):2055-2063. PMID: 37202854
Background: The modified Oxford classification mesangial and endocapillary hypercellularity, segmental sclerosis, interstitial fibrosis/tubular atrophy, and the presence of crescents (MEST-C) of immunoglobulin A nephropathy (IgAN) was recently shown to be...
8.
Koirala A, Pourafshar N, Daneshmand A, Wilcox C, Mannemuddhu S, Arora N
Adv Kidney Dis Health . 2023 Mar; 30(2):110-123. PMID: 36868727
The development of peripheral edema can often pose a significant diagnostic and therapeutic challenge for practitioners due to its association with a wide variety of underlying disorders ranging in severity....
9.
Wu M, Koirala A
Clin Nephrol Case Stud . 2023 Feb; 11:17-21. PMID: 36844260
Introduction: Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia and is associated with a variety of conditions and following hematopoietic stem cell transplantation. Chimeric antigen receptor T-cell (CAR-T) therapy...
10.
Koirala A, Jefferson J
Glomerular Dis . 2023 Feb; 1(4):237-249. PMID: 36751385
Background: Minimal change disease (MCD) causes approximately 10% of nephrotic syndrome in adults. While glucocorticoids (GCs) effectively induce remission in MCD, the disease has a high relapse rate (50-75%), and...